Navigation Links
Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer
Date:4/14/2009

Former Customer and New Vice President of Healthcare Brings 22 Years of Strategic Experience in Medical Devices

BEAVERTON, Ore., April 14 /PRNewswire/ -- Prolifiq Software, Inc., today announced that Maureen A. Shaffer has joined the company as vice president of healthcare. In this role, Shaffer will lead Prolifiq's introduction of compliant, mobile email messaging services for sales representatives in the increasingly complex regulatory environment surrounding the medical device, biotech and pharmaceutical sectors.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090414/SF98189)

"Maureen's broad industry experience in marketing medical products is a significant addition to our management team," said Jeff Gaus, CEO of Prolifiq Software. "Maureen has lived the life of our prospective customers and will allow us to better understand and serve our customers. Her deep level of insight is what will make us successful in the medical sales sector."

Maureen Shaffer brings 22 years of experience marketing complex medical technologies working with industry-leading medical device companies. Most recently, Shaffer was vice president of marketing at InSet Technologies, Inc., a developer of implantable pumps for targeted intraspinal drug delivery to treat chronic pain. Prior to that, Shaffer was vice president of marketing at AtriCure, Inc., a NASDAQ-listed pioneer in minimally invasive cardiac ablation. At both companies, Shaffer was a Prolifiq customer.

"Before Prolifiq, providing sales tools in physical, hard copy format to a worldwide sales team was expensive and slow. Digitally delivering videos, brochures, and training materials via branded, compliant email templates increases sales force effectiveness and decreases marketing costs. Sales forces can have access to the tools and templates at their mobile fingertips," says Maureen Shaffer. "In addition, the myriad regulations require diligence regarding distribution of promotional materials. Prolifiq monitors, routes for approval, and tracks customer receipt and response in real time."

Shaffer's extensive career includes launching the first angioplasty balloon with Cordis Corporation; introducing a market-changing product to replace vascular sutures at United States Surgical as director of marketing; and bringing to market more than 100 minimally invasive cardiac surgery devices at Heartport, Inc. Shaffer holds a BS in biomedical engineering from Duke University.

Medical Device Companies See the Need for Prolifiq

Medical device companies must follow complex regulations from multiple governmental bodies, both domestically at the state and federal levels as well as internationally, when sending product information to customers. Prolifiq allows sales representatives to order and send approved marketing materials electronically from mobile devices, including Blackberry, iPhone and Windows Mobile, allowing the sales team to respond immediately to medical professionals.

About Prolifiq

Prolifiq helps sales professionals use digital content in their 1:1 communications with customers and prospects. With Prolifiq's 1:1 messaging solutions, sellers match the right content to their selling conversation, wrap it in branded messages and measure the effectiveness of their communications. Customers include: Cisco Systems, General Electric, Nortel and Getty Images. For more information, visit www.prolifiq.net

Legal Notice: All rights reserved. Prolifiq is either a trademark or registered trademark and the Prolifiq logo is a trademark of Prolifiq Software, Inc. Product specifications are subject to change without notice.


'/>"/>
SOURCE Prolifiq Software, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem Completes $11 Million Private Placement Financing to Support Expansion Activities in China, Further Development of NeoStems VSEL Technology and Advancement of Medical Tourism Initiatives
2. Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations
3. ArunA Biomedical Submits Contract Proposal to Further Develop Environmental Biosensor for National Security
4. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
5. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
6. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
7. ADVENTRX Announces Further Cost-Cutting Measures
8. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
9. BN ImmunoTherapeutics Reports Further Data on PROSTVAC(TM)
10. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
11. ADVENTRX Announces Further Cost-Cutting Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 /PRNewswire -- WuXi AppTec, a leading ... and technology platform, today announced that it has ... preclinical drug discovery contract research organization (CRO). After ... wholly-owned subsidiary of WuXi, and will continue to ... greater services. The acquisition will further strengthen WuXi,s ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the full spectrum of drug and device development, and Prism Clinical Research ... and clinicians, today announced Verified Clinical Trials (VCT) has been selected ...
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
Breaking Biology Technology:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):